Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis
Summary: Metastatic cancers and recurrent cancers are diverse, different from primary cancers, and organ-dependent. However, how strong are across-cancer immune responses among different types of cancers remain unclear. Herein, vaccines-encapsulated-whole-components-of-tumor-tissue (VEWCOTT) were ap...
Main Authors: | Lu Diao, Lin Ma, Junping Cheng, Yunzhi Pan, Zuofu Peng, Lianjun Zhang, Minghao Xu, Yupei Li, Xuenong Zhang, Honglv Jiang, Guoqiang Xu, Fenghua Meng, Zhiyuan Zhong, Mi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222017837 |
Similar Items
-
Probiotics formulation and cancer nanovaccines show synergistic effect in immunotherapy and prevention of colon cancer
by: Xiangxiang Xu, et al.
Published: (2023-07-01) -
Emerging nanotechnologies in immunology : the design, applications and toxicology of nanopharmaceuticals and nanovaccines /
by: Shegokar, Ranjita., et al.
Published: (2018) -
Envelope virus-mimetic nanovaccines by hybridizing bioengineered cell membranes with bacterial vesicles
by: Mengmeng Zhang, et al.
Published: (2022-06-01) -
CpG-Based Nanovaccines for Cancer Immunotherapy
by: Chen W, et al.
Published: (2021-08-01) -
Self-adjuvanting cancer nanovaccines
by: Zhiyun Liao, et al.
Published: (2022-07-01)